Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study
AimTo evaluate the impact of a telemedicine medication management service in patients with hypertension.MethodsParticipants were allocated to either a telemedicine service (N = 173) or usual care (UC) (N = 179). The primary outcome was blood pressure (BP) reduction from baseline to the 6-month follo...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_fa0c33d02f9f4393a0fb0b678e04ea06 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Xiaoye Li |e author |
| 700 | 1 | 0 | |a Jialu Hu |e author |
| 700 | 1 | 0 | |a Yao Yao |e author |
| 700 | 1 | 0 | |a Chengchun Zuo |e author |
| 700 | 1 | 0 | |a Zi Wang |e author |
| 700 | 1 | 0 | |a Xiaoyu Li |e author |
| 700 | 1 | 0 | |a Qianzhou Lv |e author |
| 245 | 0 | 0 | |a Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study |
| 260 | |b Frontiers Media S.A., |c 2022-12-01T00:00:00Z. | ||
| 500 | |a 2296-2565 | ||
| 500 | |a 10.3389/fpubh.2022.1091484 | ||
| 520 | |a AimTo evaluate the impact of a telemedicine medication management service in patients with hypertension.MethodsParticipants were allocated to either a telemedicine service (N = 173) or usual care (UC) (N = 179). The primary outcome was blood pressure (BP) reduction from baseline to the 6-month follow-up visit, the proportion of the target BP achievement, overall adherence to prescribed medication as well as a composite of non-fatal stroke, non-fatal myocardial infarction and cardiovascular death.ResultsAt 6 months, BP was controlled in 89.6% (n = 155) of intervention patients and 78.8% (n = 141) of UC patients (OR = 1.14, 95% CI = 1.04-1.25, P = 0.006), giving a mean difference of −6.0 (−13.0 to −2.5 mmHg) and −2.0 mmHg (−4.0 to −0.1 mmHg) in SBP and DBP, respectively. 17.9% (n = 31) of the patients in the intervention group were non-adherent with medications, compared with 29.1% (n = 52) in the UC group (P = 0.014). The composite clinical endpoints were reached by 2.9% in the intervention group and 4.5% in the control group with no significant differences (OR = 1.566, 95% CI = 0.528-4.646).ConclusionTelemedicine medication management for hypertension management had led to better BP control and medication adherence improvement than UC during COVID-19 epidemic, resulting in a reduction of overall adverse cardiovascular events occurrence. | ||
| 546 | |a EN | ||
| 690 | |a telemedicine medication management | ||
| 690 | |a usual care | ||
| 690 | |a hypertension management | ||
| 690 | |a COVID-19 pandemic | ||
| 690 | |a blood pressure | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Public Health, Vol 10 (2022) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fpubh.2022.1091484/full | |
| 787 | 0 | |n https://doaj.org/toc/2296-2565 | |
| 856 | 4 | 1 | |u https://doaj.org/article/fa0c33d02f9f4393a0fb0b678e04ea06 |z Connect to this object online. |